Jones Financial Companies
ABUS icon

Jones Financial Companies’s Arbutus Biopharma ABUS Stock Holding History

Jones Financial Companies’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.56K Hold
830
– – ﹤0.01% 3969
2025
Q4 		$3.99K Hold
830
– – ﹤0.01% 3586
2025
Q3 		$3.66K Hold
830
– – ﹤0.01% 3486
2025
Q2 		$2.6K Sell
830
-872
-51% -$2.9K ﹤0.01% 3377
2025
Q1 		$5.96K Hold
1,702
– – ﹤0.01% 2899
2024
Q4 		$5.57K Buy
1,702
+872
+105% +$3.21K ﹤0.01% 2721
2024
Q3 		$3.18K Hold
830
– – ﹤0.01% 2563
2024
Q2 		$2.56K Buy
+830
New +$2.49K ﹤0.01% 2105

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $329M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return